All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Channel 4

Jazz Pharmaceuticals - Insight beyond Phase 3: does real-world evidence impact how we treat high-risk AML*? *High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)

Date
Tue, 21.09.2021
Time
08:45 - 09:45
Chairs
  • Hartmut Döhner (Ulm, Germany)
Industry Satellite Symposium Industry Satellite Symposium

What has Phase 3 data told us about increasing long-term remission in high-risk AML*?

Lecture Time
08:45 - 09:05
Speakers
  • Hartmut Döhner (Ulm, Germany)
  • Arnaud Pigneux (Bordeaux, France)
  • Roberto Lemoli (Genova, Italy)
Session Name
Industry Satellite Symposium
Location
Channel 4, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
08:45 - 09:45
Industry Satellite Symposium Industry Satellite Symposium

Do real-world studies confirm the Phase 3 data and how will they impact the management of high-risk AML*?

Lecture Time
09:05 - 09:45
Speakers
  • Hartmut Döhner (Ulm, Germany)
  • Arnaud Pigneux (Bordeaux, France)
  • Roberto Lemoli (Genova, Italy)
Session Name
Industry Satellite Symposium
Location
Channel 4, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
08:45 - 09:45